From: Methotrexate resistance in relation to treatment outcome in childhood acute lymphoblastic leukemia
 | Precursor B cell ALL | T cell ALL | Total ALL | |||
---|---|---|---|---|---|---|
 | MTX-Glu1–6 | MTX-Glu4–6 | MTX-Glu1–6 | MTX-Glu4–6 | MTX-Glu1–6 | MTX-Glu4–6 |
FPGS mRNA | ||||||
  R | −0.168 | −0.082 | 0.345 | 0.002 | 0.264 | 0.280 |
  P value | 0.456 | 0.724 | 0.176 | 0.994 | 0.104 | 0.104 |
 Number of patients | 22 | 21 | 17 | 14 | 39 | 35 |
FPGH mRNA | ||||||
  R | 0.117 | 0.195 | 0.366 | 0.537 | 0.101 | 0.045 |
  P value | 0.622 | 0.424 | 0.219 | 0.110 | 0.576 | 0.817 |
 Number of patients | 20 | 19 | 13 | 10 | 33 | 29 |
FPGS activity | ||||||
  R | 0.429* | 0.419* | 0.265 | 0.05 | 0.522* | 0.533* |
  P value | 0.005 | 0.01 | 0.431 | 0.898 | <0.001 | <0.001 |
 Number of patients | 41 | 37 | 11 | 9 | 52 | 46 |